Surgery for Parkinson's shown to have long-term benefits
This article was originally published in Clinica
Patients with advanced Parkinson's disease treated surgically by unilateral pallidotomy continue to show improvement five years after the procedure, according to a study reported in the New England Journal of Medicine (June 8). The study's follow-up period is the longest yet to be reported in the literature.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.